Pediatric Eosinophilic Gastrointestinal Disorders Link to Inborn Errors of Immunity
A study of ten patients with eosinophilic gastrointestinal disorders identified associated inborn errors of immunity and reported complete clinical remission ...
A study of ten patients with eosinophilic gastrointestinal disorders identified associated inborn errors of immunity and reported complete clinical remission ...
A new study identifies CHST3 genetic variants and food allergy as potential predictors of proton pump inhibitor response in children ...
A retrospective US telemedicine cohort study of 13,584 patients reported predominantly mild adverse events across 18,398 patient-years of personalized sublingual ...
A new review argues that innate lymphoid cells act as central coordinators of barrier tissue homeostasis, and that their dysregulation ...
Monoclonal antibody therapy, led by dupilumab, is transforming the treatment of eosinophilic esophagitis in children after decades of limited options.
A 48-week case report describes how the IL-4/IL-13 blocker dupilumab improved atopic dermatitis, asthma and eosinophilic esophagitis in a seven-year-old ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine